{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:14:06Z","timestamp":1774473246571,"version":"3.50.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n            <jats:title>Background and Purpose:<\/jats:title>\n            <jats:p>Poor-grade subarachnoid hemorrhage still has a poor prognosis. This randomized controlled clinical trial evaluated intracisternal magnesium sulfate infusion combined with intravenous hydrogen therapy in patients with poor-grade subarachnoid hemorrhage.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>\n              Thirty-seven patients with poor-grade subarachnoid hemorrhage were randomized to Mg+H\n              <jats:sub>2<\/jats:sub>\n              , Mg, and control groups. Mg and Mg+H\n              <jats:sub>2<\/jats:sub>\n              groups received intracisternal magnesium sulfate infusion (2.5 mmol\/L) at 20 mL\/h for 14 days. Mg+H\n              <jats:sub>2<\/jats:sub>\n              group also received intravenous hydrogen-rich solution infusion for 14 days. Primary outcome measures were occurrence of delayed cerebral ischemia and cerebral vasospasm. Secondary outcome measures were modified Rankin Scale and Karnofsky performance status at 3 and 12 months, Barthel index at 12 months, and serum and cerebrospinal fluid malondialdehyde and neuron-specific enolase.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>\n              Serum neuron-specific enolase levels were significantly lower in the Mg+H\n              <jats:sub>2<\/jats:sub>\n              group from days 3 to 14 than in the control group. Cerebrospinal fluid neuron-specific enolase levels were also significantly lower in the Mg+H\n              <jats:sub>2<\/jats:sub>\n              group from days 3 to 7 than in the control group. Incidences of cerebral vasospasm and delayed cerebral ischemia were significantly higher in the control group than in other groups. Modified Rankin Scale and Karnofsky performance status did not significantly differ between the three groups at 3 months. Modified Rankin Scale scores 0 to 2 were more common in the Mg and Mg+H\n              <jats:sub>2<\/jats:sub>\n              groups at 1 year. Barthel index was higher in the Mg+H\n              <jats:sub>2<\/jats:sub>\n              group than in the control group.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Intracisternal magnesium sulfate infusion started immediately after surgery reduces the incidence of cerebral vasospasm and delayed cerebral ischemia and improves clinical outcomes without complications in patients with poor-grade subarachnoid hemorrhage. Intracisternal magnesium sulfate infusion combined with intravenous hydrogen therapy decreases serum malondialdehyde and neuron-specific enolase and improves Barthel index, indicating hydrogen has additional effects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Registration:<\/jats:title>\n            <jats:p>\n              URL:\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.umin.ac.jp\/ctr\/index.htm\">https:\/\/www.umin.ac.jp\/ctr\/index.htm<\/jats:ext-link>\n              . Unique identifier: UMIN000014696.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/strokeaha.120.031260","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T10:00:29Z","timestamp":1608631229000},"page":"20-27","source":"Crossref","is-referenced-by-count":50,"title":["Intravenous Hydrogen Therapy With Intracisternal Magnesium Sulfate Infusion in Severe Aneurysmal Subarachnoid Hemorrhage"],"prefix":"10.1161","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3130-3237","authenticated-orcid":true,"given":"Satoru","family":"Takeuchi","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, National Defense Medical College, Saitama, Japan (S.T., K.K., T.T., N.O., K.W., K.M.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9384-2674","authenticated-orcid":true,"given":"Kosuke","family":"Kumagai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Defense Medical College, Saitama, Japan (S.T., K.K., T.T., N.O., K.W., K.M.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terushige","family":"Toyooka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Defense Medical College, Saitama, Japan (S.T., K.K., T.T., N.O., K.W., K.M.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Otani","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Defense Medical College, Saitama, Japan (S.T., K.K., T.T., N.O., K.W., K.M.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Defense Medical College, Saitama, Japan (S.T., K.K., T.T., N.O., K.W., K.M.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Defense Medical College, Saitama, Japan (S.T., K.K., T.T., N.O., K.W., K.M.)."},{"name":"Department of Neurosurgery, Tokyo General Hospital, Japan (K.M.)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.108.191395"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60153-6"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.28.3.660"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000314713"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13054-016-1193-9","article-title":"The critical care management of poor-grade subarachnoid haemorrhage.","volume":"20","author":"de Oliveira Manoel AL","year":"2016","unstructured":"de Oliveira Manoel, AL, Goffi, A, Marotta, TR, Schweizer, TA, Abrahamson, S, Macdonald, RL. The critical care management of poor-grade subarachnoid haemorrhage. Crit Care. 2016;20:21. doi: 10.1186\/s13054-016-1193-9","journal-title":"Crit Care"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11910-019-0990-3","article-title":"Early brain injury after poor-grade subarachnoid hemorrhage.","volume":"19","author":"Rass V","year":"2019","unstructured":"Rass, V, Helbok, R. Early brain injury after poor-grade subarachnoid hemorrhage. Curr Neurol Neurosci Rep. 2019;19:78. doi: 10.1007\/s11910-019-0990-3","journal-title":"Curr Neurol Neurosci Rep"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.30.11.2268"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2003.99.4.0644"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-211-75718-5_7"},{"key":"e_1_3_4_11_2","first-page":"529","article-title":"Early brain injury following aneurysmal subarachnoid hemorrhage: emphasis on cellular apoptosis.","volume":"22","author":"Yuksel S","year":"2012","unstructured":"Yuksel, S, Tosun, YB, Cahill, J, Solaroglu, I. Early brain injury following aneurysmal subarachnoid hemorrhage: emphasis on cellular apoptosis. Turk Neurosurg. 2012;22:529\u2013533. doi: 10.5137\/1019-5149.JTN.5731-12.1","journal-title":"Turk Neurosurg"},{"issue":"2","key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1471-4159.2012.07939.x","article-title":"Transition of research focus from vasospasm to early brain injury after subarachnoid hemorrhage.","volume":"123","author":"Caner B","year":"2012","unstructured":"Caner, B, Hou, J, Altay, O, Fujii, M, Zhang, JH. Transition of research focus from vasospasm to early brain injury after subarachnoid hemorrhage. J Neurochem. 2012;123 (suppl 2):12\u201321. doi: 10.1111\/j.1471-4159.2012.07939.x","journal-title":"J Neurochem"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000217310.88450.c3"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2045-9912-3-10","article-title":"The evolution of molecular hydrogen: a noteworthy potential therapy with clinical significance.","volume":"3","author":"Dixon BJ","year":"2013","unstructured":"Dixon, BJ, Tang, J, Zhang, JH. The evolution of molecular hydrogen: a noteworthy potential therapy with clinical significance. Med Gas Res. 2013;3:10. doi: 10.1186\/2045-9912-3-10","journal-title":"Med Gas Res"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2202-13-47","article-title":"Hydrogen-rich saline alleviates early brain injury via reducing oxidative stress and brain edema following experimental subarachnoid hemorrhage in rabbits.","volume":"13","author":"Zhuang Z","year":"2012","unstructured":"Zhuang, Z, Zhou, ML, You, WC, Zhu, L, Ma, CY, Sun, XJ, Shi, JX. Hydrogen-rich saline alleviates early brain injury via reducing oxidative stress and brain edema following experimental subarachnoid hemorrhage in rabbits. BMC Neurosci. 2012;13:47. doi: 10.1186\/1471-2202-13-47","journal-title":"BMC Neurosci"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/jnr.22739","article-title":"Beneficial effect of hydrogen-rich saline on cerebral vasospasm after experimental subarachnoid hemorrhage in rats.","volume":"90","author":"Hong Y","year":"2012","unstructured":"Hong, Y, Guo, S, Chen, S, Sun, C, Zhang, J, Sun, X. Beneficial effect of hydrogen-rich saline on cerebral vasospasm after experimental subarachnoid hemorrhage in rats. J Neurosci Res. 2012;90:1670\u20131680. doi: 10.1002\/jnr.22739","journal-title":"J Neurosci Res"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/jnr.23281","article-title":"Nuclear factor-\u03baB\/Bcl-XL pathway is involved in the protective effect of hydrogen-rich saline on the brain following experimental subarachnoid hemorrhage in rabbits.","volume":"91","author":"Zhuang Z","year":"2013","unstructured":"Zhuang, Z, Sun, XJ, Zhang, X, Liu, HD, You, WC, Ma, CY, Zhu, L, Zhou, ML, Shi, JX. Nuclear factor-\u03baB\/Bcl-XL pathway is involved in the protective effect of hydrogen-rich saline on the brain following experimental subarachnoid hemorrhage in rabbits. J Neurosci Res. 2013;91:1599\u20131608. doi: 10.1002\/jnr.23281","journal-title":"J Neurosci Res"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"e96212","DOI":"10.1371\/journal.pone.0096212","article-title":"Neuroprotective effect of hydrogen-rich saline against neurologic damage and apoptosis in early brain injury following subarachnoid hemorrhage: possible role of the Akt\/GSK3\u03b2 signaling pathway.","volume":"9","author":"Hong Y","year":"2014","unstructured":"Hong, Y, Shao, A, Wang, J, Chen, S, Wu, H, McBride, DW, Wu, Q, Sun, X, Zhang, J. Neuroprotective effect of hydrogen-rich saline against neurologic damage and apoptosis in early brain injury following subarachnoid hemorrhage: possible role of the Akt\/GSK3\u03b2 signaling pathway. PLoS One. 2014;9:e96212. doi: 10.1371\/journal.pone.0096212","journal-title":"PLoS One"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3109\/10715762.2010.500328","article-title":"Recent advances in hydrogen research as a therapeutic medical gas.","volume":"44","author":"Huang CS","year":"2010","unstructured":"Huang, CS, Kawamura, T, Toyoda, Y, Nakao, A. Recent advances in hydrogen research as a therapeutic medical gas. Free Radic Res. 2010;44:971\u2013982. doi: 10.3109\/10715762.2010.500328","journal-title":"Free Radic Res"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1179\/016164105X17288"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60724-7"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/cc10017","article-title":"Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis.","volume":"15","author":"Wong GK","year":"2011","unstructured":"Wong, GK, Boet, R, Poon, WS, Chan, MT, Gin, T, Ng, SC, Zee, BC. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis. Crit Care. 2011;15:R52. doi: 10.1186\/cc10017","journal-title":"Crit Care"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3171\/2015.1.JNS142757","article-title":"Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.","volume":"124","author":"Yamamoto T","year":"2016","unstructured":"Yamamoto, T, Mori, K, Esaki, T, Nakao, Y, Tokugawa, J, Watanabe, M. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial. J Neurosurg. 2016;124:18\u201326. doi: 10.3171\/2015.1.JNS142757","journal-title":"J Neurosurg"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12883-014-0176-1","article-title":"Effects of intravenous infusion of hydrogen-rich fluid combined with intra-cisternal infusion of magnesium sulfate in severe aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.","volume":"14","author":"Takeuchi S","year":"2014","unstructured":"Takeuchi, S, Mori, K, Arimoto, H, Fujii, K, Nagatani, K, Tomura, S, Otani, N, Osada, H, Wada, K. Effects of intravenous infusion of hydrogen-rich fluid combined with intra-cisternal infusion of magnesium sulfate in severe aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial. BMC Neurol. 2014;14:176. doi: 10.1186\/s12883-014-0176-1","journal-title":"BMC Neurol"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0028-1085422","article-title":"Lateral supraorbital keyhole approach to clip unruptured anterior communicating artery aneurysms.","volume":"51","author":"Mori K","year":"2008","unstructured":"Mori, K, Yamamoto, T, Nakao, Y, Oyama, K, Esaki, T, Watanabe, M, Nonaka, S, Hara, T, Honma, K. Lateral supraorbital keyhole approach to clip unruptured anterior communicating artery aneurysms. Minim Invasive Neurosurg. 2008;51:292\u2013297. doi: 10.1055\/s-0028-1085422","journal-title":"Minim Invasive Neurosurg"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2045-9912-3-13","article-title":"Safety of intravenous administration of hydrogen-enriched fluid in patients with acute cerebral ischemia: initial clinical studies.","volume":"3","author":"Nagatani K","year":"2013","unstructured":"Nagatani, K, Nawashiro, H, Takeuchi, S, Tomura, S, Otani, N, Osada, H, Wada, K, Katoh, H, Tsuzuki, N, Mori, K. Safety of intravenous administration of hydrogen-enriched fluid in patients with acute cerebral ischemia: initial clinical studies. Med Gas Res. 2013;3:13. doi: 10.1186\/2045-9912-3-13","journal-title":"Med Gas Res"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.110.589275"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.16.4.562"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.108.544700"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2014.00052"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2710.2005.00642.x","article-title":"Dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage.","volume":"30","author":"van Norden AG","year":"2005","unstructured":"van Norden, AG, van den Bergh, WM, Rinkel, GJ. Dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage. J Clin Pharm Ther. 2005;30:439\u2013442. doi: 10.1111\/j.1365-2710.2005.00642.x","journal-title":"J Clin Pharm Ther"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2176\/nmc.49.139","article-title":"Initial clinical experience of vasodilatory effect of intra-cisternal infusion of magnesium sulfate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.","volume":"49","author":"Mori K","year":"2009","unstructured":"Mori, K, Yamamoto, T, Nakao, Y, Osada, H, Hara, Y, Oyama, K, Esaki, T. Initial clinical experience of vasodilatory effect of intra-cisternal infusion of magnesium sulfate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 2009;49:139\u2013144; discussion 144. doi: 10.2176\/nmc.49.139","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/CCM.0b013e3181d9da1e","article-title":"Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.","volume":"38","author":"Westermaier T","year":"2010","unstructured":"Westermaier, T, Stetter, C, Vince, GH, Pham, M, Tejon, JP, Eriskat, J, Kunze, E, Matthies, C, Ernestus, RI, Solymosi, L, et al. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study. Crit Care Med. 2010;38:1284\u20131290. doi: 10.1097\/CCM.0b013e3181d9da1e","journal-title":"Crit Care Med"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1038\/srep05485","article-title":"Estimation of the hydrogen concentration in rat tissue using an airtight tube following the administration of hydrogen via various routes.","volume":"4","author":"Liu C","year":"2014","unstructured":"Liu, C, Kurokawa, R, Fujino, M, Hirano, S, Sato, B, Li, XK. Estimation of the hydrogen concentration in rat tissue using an airtight tube following the administration of hydrogen via various routes. Sci Rep. 2014;4:5485. doi: 10.1038\/srep05485","journal-title":"Sci Rep"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4103\/2045-9912.248264","article-title":"Inhalation of hydrogen gas elevates urinary 8-hydroxy-2\u2019-deoxyguanine in Parkinson\u2019s disease.","volume":"8","author":"Hirayama M","year":"2018","unstructured":"Hirayama, M, Ito, M, Minato, T, Yoritaka, A, LeBaron, TW, Ohno, K. Inhalation of hydrogen gas elevates urinary 8-hydroxy-2\u2019-deoxyguanine in Parkinson\u2019s disease. Med Gas Res. 2018;8:144\u2013149. doi: 10.4103\/2045-9912.248264","journal-title":"Med Gas Res"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2176\/nmc.oa2012-0295","article-title":"Potential risk of artificial cerebrospinal fluid solution without magnesium ion for cerebral irrigation and perfusion in neurosurgical practice.","volume":"53","author":"Mori K","year":"2013","unstructured":"Mori, K, Yamamoto, T, Miyazaki, M, Hara, Y, Koike, N, Nakao, Y. Potential risk of artificial cerebrospinal fluid solution without magnesium ion for cerebral irrigation and perfusion in neurosurgical practice. Neurol Med Chir (Tokyo). 2013;53:596\u2013600. doi: 10.2176\/nmc.oa2012-0295","journal-title":"Neurol Med Chir (Tokyo)"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/STROKEAHA.120.031260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T14:36:32Z","timestamp":1650551792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/STROKEAHA.120.031260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1161\/STROKEAHA.120.031260"],"URL":"https:\/\/doi.org\/10.1161\/strokeaha.120.031260","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}